Gilenya and Tascenso ODT are approved to treat relapsing forms of multiple sclerosis (MS) in adults. Gilenya and Tascenso ODT ...

A study examining subjective experiences after intranasal application of 5-MeO-DMT found that its effects peak 8-15 minutes ...

When news breaks, you need to understand what actually matters. At Vox, our mission is to help you make sense of the world — and that work has never been more vital. But we can’t do it on our own. We ...

In April, Imperial College London launched the Centre for Psychedelic Research, a first-of-its-kind facility focused on the study of mind-altering substances. While much of that research has centered ...

A new study from Imperial College London has found significant overlap between the experiences reported by subjects who have had near-death experiences, and volunteers administered with a powerful ...

A Canadian-based pharmaceutical company has received approval to conduct a clinical study of the psychedelic compound DMT as a treatment for stroke. Under the plan, pharmaceutical development company ...

From the dark annals of Erowid forums to Joe Rogan’s podcast studio, there’s perhaps no psychoactive drug more enigmatic — and misunderstood — than N,N-Dimethyltryptamine, better known as DMT. The ...